Eldred Rock Partners, LLC Novo Nordisk A S Transaction History
Eldred Rock Partners, LLC
- $291 Billion
- Q4 2024
A detailed history of Eldred Rock Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Eldred Rock Partners, LLC holds 75,851 shares of NVO stock, worth $6.15 Million. This represents 2.36% of its overall portfolio holdings.
Number of Shares
75,851
Previous 91,174
16.81%
Holding current value
$6.15 Million
Previous $10.9 Billion
36.76%
% of portfolio
2.36%
Previous 3.63%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,911Shares Held
318MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.64 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.17 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.16 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.08 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$991 Million3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $183B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...